Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-048202
Filing Date
2021-12-14
Accepted
2021-12-14 19:00:11
Documents
1
Period of Report
2021-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6031
  Complete submission text file 0000899243-21-048202.txt   7523
Mailing Address 101 EAST KENNEDY BLVD. SUITE 2800 TAMPA FL 33602
Business Address
Murphy Kimberly M (Reporting) CIK: 0001810474 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39802 | Film No.: 211492404

Mailing Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062
Business Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062 (847) 562-4300
Clarus Therapeutics Holdings, Inc. (Issuer) CIK: 0001817944 (see all company filings)

EIN.: 851231852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)